VTGN Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - VistaGen Therapeutics Inc - Alpha Spread
V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 3.03 USD 0.33% Market Closed
Market Cap: 82m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

Wall Street
Price Targets

VTGN Price Targets Summary
VistaGen Therapeutics Inc

Wall Street analysts forecast VTGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTGN is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

Lowest
Price Target
12.12 USD
300% Upside
Average
Price Target
13.26 USD
338% Upside
Highest
Price Target
15.75 USD
420% Upside
VistaGen Therapeutics Inc Competitors:
Price Targets
GBIO
Generation Bio Co
220% Upside
2160
GNI Group Ltd
37% Upside
KRON
Kronos Bio Inc
357% Upside
301047
Sino Biological Inc
51% Upside
397030
AprilBio Co Ltd
20% Upside
ALKS
Alkermes Plc
23% Upside
INO
Inovio Pharmaceuticals Inc
197% Upside
VICO
Vicore Pharma Holding AB
311% Upside

Revenue
Forecast

Revenue Estimate
VistaGen Therapeutics Inc

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 3 years is 69%.

N/A
Past Growth
69%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTGN's stock price target?
Price Target
13.26 USD

According to Wall Street analysts, the average 1-year price target for VTGN is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

What is VistaGen Therapeutics Inc's Revenue forecast?
Projected CAGR
69%

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 3 years is 69%.

Back to Top